In September 2022, 72 IPhO student chapters from across the country embarked on a six-month professional journey to create a drug development plan that would bring a theoretical new bladder cancer medicine to market.

This year's winning team did an extraordinary job putting together a comprehensive drug development plan and was especially impressive when justifying their thinking at key decision points throughout the competition. Congratulations to our winning team members for going above and beyond at every stage!

Team representatives will present their case at the annual BCAN Bladder Cancer Think Tank Meeting in Washington, DC this August.